Skip to main content
. Author manuscript; available in PMC: 2012 Sep 1.
Published in final edited form as: Genes Chromosomes Cancer. 2011 Jun 2;50(9):735–745. doi: 10.1002/gcc.20895

Figure 2.

Figure 2

Quantitative RT-PCR of CDKN2A, CDKN2B, WT1, SFRP1, SFRP2 and SFRP4 mRNA in parathyroid tumors of the validation cohort, showing reduced gene expression of all six selected genes in parathyroid adenomas (n=37) and carcinomas (n=7). Reduction of gene expression was significant versus normal parathyroid (p<0.01). Values represent normalized target gene/GAPDH mRNA ratio.